UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Übersicht – Operative Therapie des Nierenkarzinoms

TumorDiagnostik & Therapie, 2014-06, Vol.35 (4), p.198-203

Roigas, J.

2014

Volltextzugriff (PDF)

Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks

European journal of surgical oncology, 2013-04, Vol.39 (4), p.372-379

2013

Volltextzugriff (PDF)

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

The lancet oncology, 2015-02, Vol.16 (2), p.152-160

2015

Volltextzugriff (PDF)

Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database

International urology and nephrology, 2017-02, Vol.49 (2), p.247-254

2017

Volltextzugriff (PDF)

Differenzialtherapie beim metastasierenden Nierenzellkarzinom

Der Onkologe, 2008-02, Vol.14 (2), p.191-197

2008

Volltextzugriff (PDF)

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

European journal of surgical oncology, 2012-07, Vol.38 (7), p.637-642

2012

Volltextzugriff (PDF)

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation

World journal of urology, 2014-04, Vol.32 (2), p.365-371

2014

Volltextzugriff (PDF)

Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

British journal of cancer, 2006-08, Vol.95 (4), p.463-469

2006

Volltextzugriff (PDF)

Interleukin-2/interferon- alpha 2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

British journal of cancer, 2006-08, Vol.95 (4), p.463-469

2006

Volltextzugriff (PDF)

Peri‐operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score‐weighted European multicentre study

BJU international, 2018-01, Vol.121 (1), p.101-110

2018

Volltextzugriff (PDF)

Auswirkungen geänderter Einschlusskriterien und negativer Berichterstattung zum PSA-Screening auf die Zahl potentiell für die PREFERE-Studie rekrutierbarer Patienten

Urologe. Ausgabe A, 2016-09, Vol.55 (9), p.1213-1217

2016

Volltextzugriff (PDF)

Minimal-invasive Therapieoptionen beim Nierenzellkarzinom

Onkologie (Heidelberg, Germany), 2008-10, Vol.14 (10), p.1000-1012

2008

Volltextzugriff (PDF)

The use of Neoadjuvant Chemotherapy in Patients with Urothelial Carcinoma of the Bladder: Current Practice among Clinicians

Clinical genitourinary cancer, 2017-06, Vol.15 (3), p.356-362

2017

Volltextzugriff (PDF)

7145 Evaluation of safety, tolerability and activity: a registry for Temsirolimus-treated patients with advanced or metastatic renal cell carcinoma (aRCC) in the usual health care setting

European journal of cancer supplements, 2009, Vol.7 (2), p.437-437

2009

Volltextzugriff (PDF)

Concordance of the Gleason score in prostate multibiopsy and definitive histology

Aktuelle Urologie, 2010-05, Vol.41 (3), p.184

2010

Volltextzugriff (PDF)

Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma

Urolithiasis, 2003-12, Vol.31 (6), p.358-362

2003

Volltextzugriff (PDF)

Heat shock protein (HSP72) surface expression enhances the lysis of a human renal cell carcinoma by IL-2 stimulated NK cells

Advances in experimental medicine and biology, 1998, Vol.451, p.225

1998

Volltextzugriff (PDF)

Longterm Outcomes of Living Donor Kidney Transplants in Pediatric Recipients Following Laparoscopic vs. Open Donor Nephrectomy: Role of Renal Artery Multiplicity: 2166

Transplantation, 2012-11, Vol.94 (10S), p.1209

2012

Volltextzugriff (PDF)

Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011

World journal of urology, 2017-02, Vol.35 (2), p.245-250

2017

Volltextzugriff (PDF)

Laparoscopic Radical Nephrectomy: Techniques, Results and Oncological Outcome in 125 Consecutive Cases

European urology, 2004-04, Vol.45 (4), p.483-489

2004

Volltextzugriff (PDF)

Estramustine phosphate enhances the effects of hyperthermia and induces the small heat shock protein HSP27 in the human prostate carcinoma cell line PC-3

Urolithiasis, 2002-05, Vol.30 (2), p.130-135

2002

Volltextzugriff (PDF)

Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study

Folia biologica, 2003, Vol.49 (5), p.183-190

2003

Volltextzugriff (PDF)

Evaluation of safety, tolerability, and activity: A registry for temsirolimus-treated patients with advanced or metastatic renal cell carcinoma (aRCC) in the usual health care setting

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e15127-e15127

2010

Volltextzugriff (PDF)

Minimal-invasive Operationstechniken bei kleinen Nierentumoren

Onkologie (Heidelberg, Germany), 2004-09, Vol.10 (9), p.959-967

2004

Volltextzugriff (PDF)

Effects of modified inclusion criteria and negative reporting about PSA screening on the number of potentially recruitable patients for the PREFERE study

Urologe. Ausgabe A, 2016-09, Vol.55 (9), p.1213

2016

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(252)

Publikationsform

Sprache

Englisch
(132)
Französisch
(119)
Deutsch
(64)
Russisch
(3)
Spanisch
(1)
Estnisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(65)
Male
(54)
Aged
(46)
Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Middle Aged
(43)
Female
(38)
Urology
(38)
Urology & Nephrology
(32)
Neoplasm Staging
(27)
Adult
(25)
Oncology
(21)
Urinary Bladder Neoplasms - Pathology
(21)
Urinary Bladder Neoplasms - Surgery
(21)
Prognosis
(18)
Follow-Up Studies
(17)
Treatment Outcome
(17)
Medicine
(16)
Medicine & Public Health
(16)
Radical Cystectomy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Übersicht – Operative Therapie des Nierenkarzinoms

Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database

Differenzialtherapie beim metastasierenden Nierenzellkarzinom

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation

Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

Interleukin-2/interferon- alpha 2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

Peri‐operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score‐weighted European multicentre study

Auswirkungen geänderter Einschlusskriterien und negativer Berichterstattung zum PSA-Screening auf die Zahl potentiell für die PREFERE-Studie rekrutierbarer Patienten

Minimal-invasive Therapieoptionen beim Nierenzellkarzinom

The use of Neoadjuvant Chemotherapy in Patients with Urothelial Carcinoma of the Bladder: Current Practice among Clinicians

7145 Evaluation of safety, tolerability and activity: a registry for Temsirolimus-treated patients with advanced or metastatic renal cell carcinoma (aRCC) in the usual health care setting

Concordance of the Gleason score in prostate multibiopsy and definitive histology

Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma

Heat shock protein (HSP72) surface expression enhances the lysis of a human renal cell carcinoma by IL-2 stimulated NK cells

Longterm Outcomes of Living Donor Kidney Transplants in Pediatric Recipients Following Laparoscopic vs. Open Donor Nephrectomy: Role of Renal Artery Multiplicity: 2166

Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011

Laparoscopic Radical Nephrectomy: Techniques, Results and Oncological Outcome in 125 Consecutive Cases

Estramustine phosphate enhances the effects of hyperthermia and induces the small heat shock protein HSP27 in the human prostate carcinoma cell line PC-3

Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study

Evaluation of safety, tolerability, and activity: A registry for temsirolimus-treated patients with advanced or metastatic renal cell carcinoma (aRCC) in the usual health care setting

Minimal-invasive Operationstechniken bei kleinen Nierentumoren

Effects of modified inclusion criteria and negative reporting about PSA screening on the number of potentially recruitable patients for the PREFERE study

Aktive Filter

Suchergebnisse filtern